Loading…
CalciMedica, Inc. is projected to rise to $1.09 by 2027, a +47% move from its current price of $0.7446. CALC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.7067 | $0.7457 | $0.7868 | +0.14% |
| May 30 | $0.6922 | $0.7467 | $0.8056 | +0.28% |
| May 31 | $0.6814 | $0.7478 | $0.8206 | +0.43% |
| Jun 1 | $0.6727 | $0.7488 | $0.8337 | +0.57% |
| Jun 2 | $0.6651 | $0.7499 | $0.8455 | +0.71% |
| Jun 3 | $0.6585 | $0.751 | $0.8565 | +0.86% |
| Jun 4 | $0.6525 | $0.7521 | $0.8667 | +1.00% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6525 | $0.7521 | $0.8667 | +1.00% |
| Week 2 | $0.6214 | $0.7596 | $0.9284 | +2.01% |
| Week 3 | $0.60 | $0.7672 | $0.981 | +3.03% |
| Week 4 | $0.5834 | $0.7749 | $1.03 | +4.06% |
| Week 5 | $0.5698 | $0.7826 | $1.07 | +5.11% |
| Week 6 | $0.5583 | $0.7905 | $1.12 | +6.16% |
| Week 7 | $0.5484 | $0.7984 | $1.16 | +7.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia.
The company is based in La Jolla, California, and operates in the healthcare sector, developing therapies that target inflammatory and immunologic pathways and related tissue injury.
CalciMedica, Inc. (CALC) is a healthcare stock currently trading at $0.7446 with a market cap of $11.76M and a rank of 5050. The current price and market position provide the baseline for the long-run forecast horizon.
Near term, the forecast for 2026 shows an average price of $0.7446 with a range from $0.507 to $1.05 and an ROI of 0%, indicating a neutral first year. The long-run outlook turns bullish from 2027 onward, with forecasted upside across multiple years and higher potential maximum prices.
A major floor 35.0% below — a decisive break under it would weaken the trend.
The nearest floor, 25.2% below — buyers have tended to step in here.
Price is pressing into resistance (2.1% away) — a breakout level to watch.
A major ceiling 652.1% above — clearing it would confirm fresh momentum.
Key CALC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CALC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6818 | Buy | $0.6987 | Buy |
| MA 10 | $0.6673 | Buy | $0.6721 | Buy |
| MA 20 | $0.6351 | Buy | $0.6509 | Buy |
| MA 50 | $0.6272 | Buy | $0.794 | Sell |
| MA 100 | $1.48 | Sell | $1.34 | Sell |
| MA 200 | $2.53 | Sell | $1.98 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.93 | Neutral |
| Stoch RSI (14) | 88.86 | Sell |
| CCI (20) | 200.04 | Buy |
| Williams %R (14) | -8.88 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 18.44 | Buy |
| Bollinger %B (20,2) | 1.05 | Sell |
| Stochastic %K (14) | 91.12 | Sell |
| TRIX (15) | 0.13 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 66.53 | Neutral |
| Momentum (10) | 0.12 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 0.72 | Buy |
| ADX (14) | 13.18 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is bullish according to the sentiment and price action data. The RSI14 is 60, positioned near the middle of typical momentum, and the 50-day simple moving average sits at $0.6272 while the 200-day SMA sits at $2.53.
Support is indicated at $0.557 and resistance at $0.76, framing a 30-day range from $0.5228 to $1.06. These levels provide near-term reference points for price action as investors weigh the stock’s fundamentals and the evolving price trajectory.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.507 | $0.7446 | $1.05 | 0% | Neutral | |
| $0.7856 | $1.09 | $1.64 | +47% | Bullish | |
| $0.7609 | $1.12 | $1.79 | +51% | Bullish | |
| $0.6718 | $1.04 | $1.75 | +40% | Bullish | |
| $0.5711 | $0.9289 | $1.62 | +25% | Bullish | |
| $0.5518 | $0.9378 | $1.69 | +26% | Bullish | |
| $0.6003 | $1.06 | $1.98 | +43% | Bullish | |
| $0.6839 | $1.26 | $2.41 | +69% | Bullish | |
| $0.7633 | $1.47 | $2.87 | +97% | Bullish | |
| $0.702 | $1.40 | $2.81 | +88% | Bullish | |
| $0.9588 | $2.13 | $4.69 | +186% | Bullish | |
| $1.09 | $2.42 | $5.57 | +225% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.507 | $0.7446 | $0.8857 | +0.00% |
| June 2026 | $0.6668 | $0.7996 | $0.9937 | +7.39% |
| July 2026 | $0.6951 | $0.8478 | $1.08 | +6.02% |
| August 2026 | $0.6478 | $0.8007 | $1.04 | -5.55% |
| September 2026 | $0.6157 | $0.7695 | $1.02 | -3.90% |
| October 2026 | $0.6415 | $0.81 | $1.08 | +5.26% |
| November 2026 | $0.6357 | $0.8099 | $1.10 | -0.02% |
| December 2026 | $0.5966 | $0.7668 | $1.05 | -5.32% |
Click any year to see its month-by-month CALC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CALC could reach as high as $1.05, with a base case around $0.7446 and support toward $0.507 — roughly 0% from $0.7446. Price action looks broadly range-bound.
Expect CALC to range from $0.7856 to $1.64 through 2027. The $1.09 average target implies a +47% move from current prices. That is up +47% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The CALC price prediction for 2028 points to an average of $1.12 (low $0.7609, high $1.79) — a potential gain of +51% on today's $0.7446. Momentum favours further upside here.
In 2029, CALC is projected to trade between $0.6718 and $1.75, averaging $1.04 — a potential gain of +40% from today's $0.7446. That is -7% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
CalciMedica, Inc.'s 2030 outlook centres on $0.9289, within a $0.5711 to $1.62 range. That is -11% versus the projected 2029 average. That marks a +25% change versus current levels. Momentum favours further upside here.
By 2031, CALC could reach as high as $1.69, with a base case around $0.9378 and support toward $0.5518 — roughly +26% from $0.7446. Buyers look set to stay in control over this stretch.
Expect CALC to range from $0.6003 to $1.98 through 2032. The $1.06 average target implies a +43% move from current prices. That is up +13% on the projected 2031 average. Momentum favours further upside here.
The CALC price prediction for 2033 points to an average of $1.26 (low $0.6839, high $2.41) — a potential gain of +69% on today's $0.7446. Buyers look set to stay in control over this stretch.
In 2034, CALC is projected to trade between $0.7633 and $2.87, averaging $1.47 — a potential gain of +97% from today's $0.7446. That is up +16% on the projected 2033 average. Momentum favours further upside here.
CalciMedica, Inc.'s 2035 outlook centres on $1.40, within a $0.702 to $2.81 range. That is -4% versus the projected 2034 average. That marks a +88% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, CALC could reach as high as $4.69, with a base case around $2.13 and support toward $0.9588 — roughly +186% from $0.7446. Momentum favours further upside here.
Expect CALC to range from $1.09 to $5.57 through 2050. The $2.42 average target implies a +225% move from current prices. That is up +14% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CALC today (≈ 1,343.002955 CALC) could be worth
$3,254.23
+$2,254.23 (+225%) by 2050 · US Dollar
Based on the average projected CALC price of $2.42 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CALCwould be worth at today's price.
$1,000 invested in CALC on May 27, 2025 (≈ 568.181821 CALC) would be worth
$423.07
-$576.93 (-57.7%) today · 0.42× · US Dollar
Based on a CALC entry price of $1.76 vs. today's $0.7446.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.645 | $1,154.42 | +15.4% |
| 1 month ago | $0.59 | $1,262.03 | +26.2% |
| 3 months ago | $0.552 | $1,348.91 | +34.9% |
| 6 months ago | $4.27 | $174.38 | -82.6% |
| 1 year ago | $1.76 | $423.07 | -57.7% |
| All time (3.0y) ago | $5.84 | $127.5 | -87.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CALC forecast.
Our base-case forecast reaches $1.50 around 2040.
Implied market cap at $1.50: $23.7M
The multi-year forecast shows sustained bullish sentiment with rising average prices and meaningful upside potential. In 2030, the average price is forecast at $0.9289 with a max of $1.62 and a min of $0.5711, for an estimated ROI of 24.8%. By 2040, the average rises to $2.13 with a max of $4.69 and a min of $0.9588, delivering a forecasted ROI of 186.2%.
By 2050, the average price is projected at $2.42, with a max of $5.57 and a min of $1.09, and a forecasted ROI of 225.4%. Across these years, the sentiment remains BULLISH, highlighting upside potential amid the long-range forecast. These figures are estimates and not guarantees, reflecting potential rather than certainty, and should be considered within the context of risk and uncertainty in healthcare equities.
Tap a question to reveal the answer.
The 2027 forecast shows an average price of $1.09, with a min of $0.7856 and a max of $1.64, and an ROI of 46.6% with a BULLISH sentiment.
Yes, the 2034 forecast projects an average of $1.47 with a max of $2.87 and a min of $0.7633, and a ROI of 96.8% with a BULLISH sentiment.
The 2029 forecast shows an average price of $1.04, with a min of $0.6718 and a max of $1.75, and a ROI of 40% with a BULLISH sentiment.
For 2030 the average is $0.9289 (min $0.5711, max $1.62) with ROI 24.8% and BULLISH sentiment; by 2040 the average is $2.13 (min $0.9588, max $4.69) with ROI 186.2%; by 2050 the average is $2.42 (min $1.09, max $5.57) with ROI 225.4% and BULLISH sentiment.
The long-term forecast suggests continued upside, with 2030, 2040, and 2050 showing rising averages and strong max values (up to $5.57 in 2050) and high ROIs (up to 225.4%). The sentiment remains BULLISH across the later years, but these are estimates and not guarantees.
CalciMedica, Inc. Community Discussion
0Share your CalciMedica, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.